Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
Manulife Financial (TSX:MFC) has recently drawn attention as its shares have moved over the past month and past 3 months, prompting investors to reassess the insurer’s valuation and recent financial metrics.
See our latest analysis for Manulife Financial.
The recent 10.15% 1 month share price return contrasts with a 1.90% 3 month share price decline, while the 1 year total shareholder return of 35.01% points to momentum that has built over a longer period.
If Manulife’s move has you reassessing your portfolio, it could be a good moment to broaden your search with the 2 top founder-led companies
With a recent 10.15% 1 month gain, a 35.01% 1 year total return, and shares trading around CA$50.56 compared with a CA$54.78 price target, is Manulife still undervalued or is the market already pricing in future growth?
The most followed narrative pegs Manulife Financial’s fair value at CA$54.71, a touch above the last close of CA$50.56, framing the recent share price moves against longer term earnings and revenue assumptions.
The acquisition of Comvest Credit Partners meaningfully scales Manulife’s private markets platform and introduces high-growth, fee-based private credit capabilities; leveraging Manulife’s global distribution, especially into Asia’s fast-growing wealth pools, should drive a higher mix of stable, capital-light fee income, thereby improving net margins and supporting core EPS and ROE growth.
Curious what earnings, margin and valuation path has to line up for that fair value to hold? The narrative leans on ambitious growth, disciplined capital use and a specific future profit multiple, all under a 6.25% discount rate. The full breakdown shows how those moving parts fit together.
Result: Fair Value of CA$54.71 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this hinges on key risks. These include credit losses in U.S. loan and real estate exposures, as well as potential earnings pressure from Hong Kong MPF fee compression.
Find out about the key risks to this Manulife Financial narrative.
The narrative prices Manulife at a 7.6% discount to its CA$54.71 fair value, yet the current P/E of 16.1x sits above the North American insurance group at 12.3x, the peer average at 15.3x, and even its own 15x fair ratio. That gap points to valuation risk rather than a clear bargain. How much of the story do you think is already in the price?
